Unmatched Founder-Problem Fit

Team

Ed Bullmore, MD/PhD

Chief Scientific Officer

Jakob Seidlitz, PhD

Chief Executive Officer

Josh Bernstock, MD/PhD

Chief Medical Officer

Professor of Psychiatry at the University of Cambridge. Pioneer of network analytics in human neuroscience and former VP of Experimental Medicine at GlaxoSmithKline. King’s College London PhD, University of Oxford MD.

Early career scientist at the Children’s Hospital of Philadelphia. Unique expertise across neurobiology, medical image processing and data science, and integrative bioinformatics. University of Cambridge PhD.

Scientist-surgeon at MIT, Brigham and Women’s and Boston Children’s Hospitals. Unique expertise in drug repositioning and development of novel/experimental immunotherapeutics. University of Cambridge PhD, University of Alabama at Birmingham MD.

Meera Srikrishna, PhD

Lead Data Scientist

Michael Schöll, PhD

Chief Innovation Officer

Richard Bethlehem, PhD

Chief Technology Officer

Scientist at the University of Gothenburg. Unique expertise in computer vision and deep learning analytical methods for brain imaging. University of Gothenburg PhD.

Professor of Molecular Medicine at the University of Gothenburg and Principal Research Fellow at University College London. Specializes in biomarker development for neurodegenerative disorders. Karolinska Institutet PhD.

Assistant Professor in Neuroinformatics at the University of Cambridge. Unique expertise in neurodevelopment, big data analytics, and machine learning. University of Cambridge PhD.

Advisory Board

Aaron Alexander-Bloch, MD/PhD

Scientific Advisor

Hannah Mamuszka, MS

Scientific Advisor

Simon White, PhD

Scientific Advisor

Assistant Professor and Attending Psychiatrist at the Children’s Hospital of Philadelphia. Unique expertise in network science, neuroimaging-genetics, University of Cambridge PhD, University of California Los Angeles MD.

Founder and CEO of Alva10, an advisory firm established in March 2016, and Managing Partner of 10Edison, a diagnostics-focused venture fund. Specializes in creating partnerships between payers and diagnostic companies to enhance the value of diagnostic technology. Harvard University MS.

Senior Investigator at the University of Cambridge. Unique expertise in multivariate biostatistics, epidemiology, and related high-performance computing applications. University of Nottingham PhD.

Team

EDWARD T. BULLMORE

Chief Scientific Officer

Professor of Psychiatry at University of Cambridge. Pioneer of network analytics in human neuroscience and former VP of Experimental Medicine at GlaxoSmithKline. King’s College London PhD, University of Oxford MD.

JAKOB SEIDLITZ

Chief Executive Officer

Early career scientist at Children’s Hospital of Philadelphia and University of Pennsylvania. Unique expertise across neurobiology, medical image processing and data science, and integrative bioinformatics. University of Cambridge PhD.

JOSH BERNSTOCK

Chief Medical Officer

Scientist/surgeon at MIT, Brigham and Women’s and Boston Children’s Hospitals. Unique expertise in the repositioning of approved drugs and the development/characterization of novel/experimental immunotherapeutics. University of Cambridge PhD, University of Alabama at Birmingham MD.

MEERA SRIKRISHNA

Lead Data Scientist

Postdoctoral fellow from University of Gothenburg, Sweden working predominantly on the application of computer vision and deep learning analytical methods on brain imaging. During her Ph.D., she worked on applications of deep learning to derive brain CT-based quantitative measures.
She pursued her Master's degree in biomedical engineering and worked for the National Brain Research Centre, India between 2015-17. She is passionate about bridging the gap between academia and industry, aiming to apply Al innovations to improve clinical workflows.

MICHAEL SCHOLL

Chief Innovation Officer

A Professor of Molecular Medicine at the University of Gothenburg and Principal Research Fellow at University College London, our expert, with a PhD from the Karolinska Institutet, specializes in developing biomarkers for neurodegenerative disorders.
Recognized for his contributions, he has received prestigious awards, including the Queen of Sweden's Award in 2018 and the Birger Karlsson Prize in 2022. Elected to the Swedish Young Academy in 2021 and the Brain Pool of the National Research Foundation of Korea in 2023, his work is funded by major grants from Swedish, European, and US sources.

RICHARD A.I. BETHLEHEM

Chief Technical Officer

Assistant Professor in Neuroinformatics at University of Cambridge. Unique expertise in neurodevelopment, big data analytics, and machine learning. University of Cambridge PhD.

Scientific Advisors

AARON ALEXANDER-BLOCH

Scientific Advisor

Assistant Professor and Attending Psychiatrist at Children’s Hospital of Philadelphia and University of Pennsylvania. Unique expertise in network science, neuroimaging-genetics, University of Cambridge PhD, University of California Los Angeles MD.

HANNA MAMUSZKA

Scientific Advisor

As the founder and CEO of Alva10, an advisory firm established in March 2016, she specializes in creating partnerships between payers and diagnostic companies to enhance the value of diagnostic technology.
With extensive experience, she served as Vice President of Business Development and Clinical Strategy at Exosome Diagnostics from 2010 to 2015 and held various director-level positions at companies like Asuragen, Inc. and Oncotech Inc. Notably, she's been Executive Director of Precision Care Alliance, focusing on policy reform for diagnostic development. Ms. Mamuszka's career also includes diverse laboratory roles, including at ArQule.

SIMON WHITE

Scientific Advisor

Senior Investigator at University of Cambridge. Unique expertise in multivariate biostatistics, epidemiology, and related high-performance computing applications. University of Nottingham PhD.

Revolutionizing Healthcare: Propel the Future with Data-Driven Solutions for Brain Disorders!

Be part of this cutting-edge technology by supporting our groundbreaking initiative in population analytics for individual diagnostics. Join us in shaping the future of healthcare innovation.

Send us a message

Verified by MonsterInsights